AIM ImmunoTech Inc

NYSE American: AIM    
Share price (5/10/24): $0.43    
Market cap (5/10/24): $21.5 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.25
from 10-K 3 pages Description of Common Stock
12/34/56
EX-4.6
from 8-A12B/A 49 pages AIM ImmunoTech Inc. [F/K/a Hemispherx Biopharma, Inc.] and American Stock Transfer & Trust Company, LLC, Rights Agent Third Amended and Restated Rights Agreement
12/34/56
EX-4.25
from 10-K 2 pages Description of Common Stock
12/34/56
EX-4.5
from 8-A12B/A 3 pages Amendment to the Second Amended and Restated Rights Agreement of AIM ImmunoTech Inc
12/34/56
EX-4.1
from 10-Q 3 pages Amendment to the Second Amended and Restated Rights Agreement of AIM ImmunoTech Inc
12/34/56
EX-4.23
from 10-K 2 pages Description of Common Stock
12/34/56
EX-4.4
from S-3 33 pages AIM ImmunoTech Inc., as Issuer and [ ], as Indenture Trustee Indenture Dated as of [ ]
12/34/56
EX-4.23
from 10-K 2 pages Description of Common Stock
12/34/56
EX-4.1
from S-8 18 pages Hemispherx Biopharma, Inc. Amended and Restated 2018 Equity Incentive Plan Adopted by the Board of Directors Effective as of July 2, 2018 & Approved by the Stockholders: September 12, 2018 as Amended by the Board of Directors Effective as of August 19, 2019 Approved by the Stockholders: October _, 2019 Termination Date: September 12, 2028
12/34/56
EX-4.23
from 10-K 2 pages Description of Common Stock
12/34/56
EX-4.2
from 8-K 17 pages Common Stock Purchase Warrant AIM ImmunoTech Inc
12/34/56
EX-4.1
from 8-K 16 pages Pre-Funded Common Stock Purchase Warrant AIM ImmunoTech Inc
12/34/56
EX-4.20
from S-1/A 15 pages Common Stock Purchase Warrant for the Purchase of [ ] Shares of Common Stock of AIM ImmunoTech Inc
12/34/56
EX-4.18
from S-1 17 pages Common Stock Purchase Warrant AIM ImmunoTech Inc
12/34/56
EX-4.17
from S-1 17 pages Pre-Funded Common Stock Purchase Warrant AIM ImmunoTech Inc
12/34/56
EX-4.1
from 8-K 15 pages Hemispherx Biopharma, Inc. and American Stock Transfer & Trust Company, LLC, as Warrant Agent Warrant Agency Agreement Dated as of March 8, 2019 Warrant Agency Agreement
12/34/56
EX-4.1
from 8-K 22 pages Form of Common Stock Purchase Warrant Hemispherx Biopharma, Inc
12/34/56
EX-4.15
from S-1/A 15 pages Hemispherx Biopharma, Inc. and American Stock Transfer & Trust Company, LLC, as Warrant Agent Warrant Agency Agreement Dated as of February __, 2019 Warrant Agency Agreement
12/34/56
EX-4.14
from S-1/A 3 pages Indenture or similar
12/34/56
EX-4.1
from S-8 21 pages Hemispherx Biopharma, Inc. 2018 Equity Incentive Plan Adopted by the Board of Directors Effective as of July 2, 2018 & Approved by the Stockholders: September 12, 2018 Termination Date: September 12, 2028
12/34/56